Male spermatogenesis is a complex biological process that is regulated by hormonal signals from the hypothalamus (GnRH), the pituitary gonadotropins (LH and FSH) and the testis (androgens, inhibin). The two key somatic cell types of the testis, Leydig and Sertoli cells, respond to gonadotropins and androgens and regulate the development and maturation of fertilization competent spermatozoa. Although progress has been made in the identification of specific transcripts that are translated in Sertoli and Leydig cells and their response to hormones, efforts to expand these studies have been restricted by technical hurdles. In order to address this problem we have applied an in vivo ribosome tagging strategy (RiboTag) that allows a detailed and physiologically relevant characterization of the “translatome” (polysome-associated mRNAs) of Leydig or Sertoli cells in vivo. Our analysis identified all previously characterized Leydig and Sertoli cell-specific markers and identified in a comprehensive manner novel markers of Leydig and Sertoli cells; the translational response of these two cell types to gonadotropins or testosterone was also investigated. Modulation of a small subset of Sertoli cell genes occurred after FSH and testosterone stimulation. However, Leydig cells responded robustly to gonadotropin deprivation and LH restoration with acute changes in polysome-associated mRNAs. These studies identified the transcription factors that are induced by LH stimulation, uncovered novel potential regulators of LH signaling and steroidogenesis, and demonstrate the effects of LH on the translational machinery in vivo in the Leydig cell.
Citation: Sanz E, Evanoff R, Quintana A, Evans E, Miller JA, Ko C, et al. (2013) RiboTag Analysis of Actively Translated mRNAs in Sertoli and Leydig Cells In Vivo. PLoS ONE 8(6): e66179. doi:10.1371/journal.pone.0066179
Editor: Stefan Schlatt, University Hospital of Münster, Germany
Received: March 3, 2013; Accepted: May 2, 2013; Published: June 11, 2013
Copyright: © 2013 Sanz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/National Institutes of Health (NIH) grant 1R21HD057790-01 (P.S.A.) and 2 R01 HD010808 (M.D.G); the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/NIH through cooperative agreement grant U54HD12629 as part of the Specialized Centers Program in Reproduction and Infertility Research (Project 3, G.S.M.); the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/NIH Contraception Center Research Grant U54 HD042454 (M.D.G.) and MH086386 to G.S.M. and P.S.A. E.S. and A.Q. were supported by the postdoctoral mobility program of the Spanish Ministry of Science and Innovation (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
In mammals, male reproductive capacity is maintained via a complex network of positive and negative feedback loops that act anatomically at the level of the hypothalamus, the pituitary and the gonad (referred to as the HPG axis) , . Pulsatile release of Gonadotropin-releasing hormone (GnRH) from neurons located in the preoptic area of the hypothalamus into the hypophysial portal circulation acts on the gonadotropes of the anterior pituitary to cause release of the gonadotropins LH and FSH , . LH and FSH act on the somatic Leydig and Sertoli cells of the testis, respectively, to stimulate steroidogenesis and support spermatogenesis, while factors such as the inhibins produced by Sertoli cells and androgens produced by the Leydig cells feedback negatively at the level of the hypothalamus and pituitary to reduce GnRH, LH and FSH levels , , .
Leydig and Sertoli cells are primary responders to circulating gonadotropin hormones and support the development of germ cells. Failure of the somatic cells of the testis to respond appropriately to hormonal cues within the HPG axis or to create the appropriate local spermatogonial stem cell niche can result in male infertility , , . Pharmacological disruption of Leydig or Sertoli cell function also represents a potential avenue for the development male contraceptives .
Although significant progress has been made toward understanding testicular function and global gene expression changes in testis using a combination of surgical, pharmacological or genetic manipulations and genome-scale analysis , , , , determining cell type-specific gene expression changes in vivo in the testis has been difficult due to lack of appropriate tools. Previous strategies to identify cell-type-specific gene expression in testis have relied on either partially purified cell populations or the use of genetic models such as the hypogonadal mouse (HPG), where testis development can be initiated de novo by administration of GnRH, gonadotropins or testosterone (T) , , , , , , , . However, a cell-specific characterization of the transcriptional dynamics of testicular somatic cells in vivo in a physiologically relevant context has yet to be achieved. In the present study, we took advantage of the recently developed RiboTag mouse line  to epitope-tag ribosomes from either Leydig or Sertoli cells and isolate cell-specific mRNAs that are actively being translated in the adult mouse in vivo. This approach allowed us to identify novel mRNAs expressed in these somatic cell types and provide a detailed characterization of the effect of gonadotropins and testosterone on translatome dynamics in Leydig and Sertoli cells in vivo.
Materials and Methods
All mouse procedures were approved under protocol 2022-01, titled “Regulation of cAMP-Dependent Protein Kinase Genes, by our Institutional Animal Care and Use Committee (IACUC) at the University of Washington, which operates under approval number A3464-01 from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC).
Animal Maintenance and Treatments
Mice were housed in a temperature and humidity controlled facility with a 12-h light/dark cycle. Leydig cell-specific (Cyp17iCre: RiboTag) and Sertoli cell-specific (AMH-Cre: RiboTag) RiboTag mice were obtained by crossing RiboTag homozygous mice  with Cyp17iCre  or AMH-Cre mice . Cyp17iCre mice were obtained from Dr. CheMyong Ko and AMH-Cre mice were provided by Dr. Robert E. Braun. For in vivo LH treatment experiments, mice were injected subcutaneously with 300 ug of the GnRH antagonist acyline (a generous gift of Dr. John K. Amory) every 24 h for 4 days before a single intraperitoneal injection of 2 units of purified human LH (Scripps laboratories). After treatments, mice were sacrificed by CO2 asphyxiation or a single Beuthanasia-D injection.
After treatments, testes were homogenized and immunoprecipitation was performed as described previously  with minor modifications. Briefly, 10 ul of anti-HA antibody (Covance) were coupled to 200 ul of beads in citrate-phosphate buffer pH 5.0 and the antibody-bead complex was added to the cleared homogenates and incubated overnight at 4°C. After incubation, beads were washed in high salt buffer 3 times for 5 min, resuspended in RLT buffer (with beta-mercaptoethanol; Qiagen) and stored at −80°C until RNA extraction.
LH, FSH and Testosterone Serum Determination
After treatments, blood was obtained by cardiac puncture and allowed to clot in Microtainer serum separator tubes (Becton-Dickinson) for 1 h at RT. Serum was recovered by centrifugation and stored at −80°C for later analysis. LH and FSH serum levels were determined by RIA at the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core, and testosterone levels were determined using the Testosterone EIA kit (Cayman Chemical).
RNA from the inputs (50 ul) and the pellets was obtained using the RNeasy mini kit (Qiagen) according to manufacturer's directions. Total RNA was quantified using a NanoDrop 1000 spectrophotometer (Thermo Scientific) and its quality was assessed using an Agilent 2100 Bioanalyzer with the RNA 6000 Nano kit (Agilent Technologies).
100 ng of RNA was amplified and labeled using NuGen Ovation labeling kit and hybridized to Affymetrix GeneChip Mouse Gene 1.0 ST Arrays. Array output was normalized using the RMA algorithm, and data analysis was conducted using GeneSpring (Version 11.0.2; Agilent Technologies). Genes were considered to be regulated if they 1) had a raw score of greater than 50 in at least one sample, 2) were determined to be significantly different versus controls by ANOVA followed by Contrast analysis (p<0.05) and 3) showed a 2-fold (for IP versus input analysis) or 1.5-fold (for IP analysis) or greater increase or decrease versus controls. All samples in each experiment were included in the statistical analysis. The Affymetrix Raw.CEL files have been deposited with the National Center for Biotechnology Information Gene Expression Omnibus (Accession number: GSE45799; http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE45799). Gene ontology analysis was performed using the Web-based Gene Set Enrichment Analysis Toolkit (WebGestalt) V2. http://bioinfo.vanderbilt.edu/webgestalt/.
Hierarchical Clustering Analysis
Data from all Affymetrix.CEL files were read into R and converted from Log2 to linear space. All probes with low expression (<10% of mean) in 10 or more samples were removed. A single probe per gene was selected using collapseRows  with default settings and a Pearson correlation (R) between each pair of samples using all 18410 remaining probes was performed. Hierarchical clustering was then performed on the samples using 1-correlation as the distance measure, and the results were plotted in a dendrogram (so a height of 0.02 on the plot means that the samples have R = 0.98).
For qRT-PCR analysis, equal amounts of RNA were assessed using the Brilliant II SYBR green qRT-PCR 1-step master mix (Agilent Technologies). Relative expression values were obtained using the standard curve method and normalized to the Actb levels. Amplification efficiencies were calculated using the MxPro software (Stratagene) and were within accepted parameters (80–120%). Data for immunoprecipitates is presented as the fold change versus saline-treated animals. Enrichment is calculated as the IP versus input ratio and shows the abundance of the transcript in the targeted cell type (IP) when compared to equal amounts of RNA from the whole testis (input). Sequences of the different primer sets used were obtained from Primerbank (http://pga.mgh.harvard.edu/primerbank/)  and can be found in Table S6.
MA-10 Cell Culture
Cells were cultured as described in . 1×105 cells/ml were seeded onto gelatin-coated 6-well plates and allowed to attach for 2 days. For LH treatment, cells were incubated in serum-free medium containing 1% BSA overnight before the addition of purified human LH (0.2 Units/ml). Cells were lysed in SDS sample buffer (62.5 mM Tris, pH 6.8, 2% SDS, 10% glycerol) for protein analysis, in RLT buffer (Qiagen) for RNA extraction, or as described in  for polysome analysis. Sucrose density gradient fractionation and polysome analysis was performed as described in .
Western Blot Analysis
Protein lysates were quantified using the BCA protein assay (Pierce). After protein determination, 20 ug of protein were separated by SDS-PAGE and transferred onto nitrocellulose membranes. After transfer, membranes were blocked with 5% milk in TBST (Tris-buffered saline containing 0.1% Tween-20) and incubated overnight with the following primary antibodies: anti-Aquaporin 2 (1:1000; Novus), anti-phospho-S6 (1:2000; Cell Signaling Technologies) and anti-Beta Actin (1:50,000; Sigma-Aldrich). After incubation with secondary antibodies (1:10,000; Jackson ImmunoResearch), membranes were washed in TBST and developed using an enhanced chemiluminescence (ECL) detection system (Pierce).
Mice were perfused transcardially with Bouin fixative or PBS containing 4% paraformaldehyde and testes were removed, post-fixed overnight and cryoprotected with 30% sucrose in PBS. For cryosectioning, testes were frozen for 5 min in dry ice and sectioned using a freezing microtome (Leica). Frozen sections were mounted onto slides and stored at −80°C until ready for use. For IHC, slides were removed from −80°C and allowed to air dry for a few minutes before transferring into wash buffer (PBS with 0.2% Triton X-100). For quenching of the endogenous peroxidase, slides were immersed into 0.3% H2O2 in methanol for 30 min, and washed twice before blocking with 2.5% normal blocking serum in wash buffer. After blocking, sections were incubated with the primary antibody (biotin-labeled anti-HA antibody at 1:1000, Covance; or anti-Aquaporin 2 at 1:200, Novus) overnight at 4°C, and washed twice before the addition of the R.T.U. VECTASTAIN Elite ABC reagent or ImmPRESS reagent (Vector Labs) for 30 min. After incubation, sections were washed twice for 5 min in PBS and developed using the ImmPACT DAB peroxidase substrate (Vector). HA stained sections were also counterstained with Hematoxylin QS (Vector) before mounting with VectaMount AQ (Vector).
Activation of RiboTag in Sertoli or Leydig Cells of the Testis
In order to label ribosomes in Sertoli or Leydig cells, AMH-Cre  or Cyp17iCre mice , respectively, were crossed to RiboTag homozygous mice to obtain double heterozygote Cre: RiboTag offspring. RiboTag activation in the cell type of interest was confirmed by immunohistochemistry for hemmaglutinin (HA) in testis sections of AMH-Cre: RiboTag or Cyp17iCre: RiboTag mice (Fig. 1A). HA staining within the seminiferous tubules in AMH-Cre: RiboTag mouse sections was consistent with RiboTag activation in Sertoli cells. In Cyp17iCre: RiboTag mice, robust HA staining was observed in the interstitial spaces of the testis where Leydig cells are located; however, unexpected HA staining in scattered cells of the tubule was also observed (Fig. 1A, arrows), suggesting that the RiboTag was also activated in some non-Leydig cell types. Once the RiboTag was activated, cell type-specific transcripts were isolated from the total pool of messenger RNAs (input) by an affinity purification method using an anti-HA antibody coupled to protein G magnetic beads as depicted in Fig. 1B.
(A) RiboTag mice were crossed to a Leydig cell-specific Cre line (Cyp17iCre mice) or a Sertoli cell-specific Cre line (AMH-Cre mice) and the RiboTag activation in the cell type of interest was verified by immunohistochemistry using an anti-HA antibody in testis sections. Arrows point to an unexpected RiboTag activation in scattered cells of the tubule in the Cyp17iCre: RiboTag mice. (B) Cartoon depicting the RiboTag assay. Magnetic beads coupled to anti-HA antibodies were added to testis homogenates of Cyp17iCre: RiboTag or AMH-Cre: RiboTag mice (input of the IP) and incubated overnight at 4°C to capture the HA-tagged polysomes from Leydig or Sertoli cells. After incubation, immunoprecipitates were recovered prior to RNA isolation and analysis. (C) Microarray analysis results confirm the enrichment for well-established Sertoli cell-specific transcripts, as well as the negative enrichment for Leydig and germ cell markers in the IPs from AMH-Cre: RiboTag mice. (D) Similar analysis in Cyp17iCre: RiboTag IPs revealed a significant enrichment for Leydig cell-specific transcripts and a negative enrichment for germ cell-specific mRNAs. Sertoli cell specific transcripts did not show a significant negative enrichment consistent with the RiboTag activation in some Sertoli cells. The enrichment was calculated as the ratio of the signal in the IPs to their inputs.
The RiboTag Assay Reveals Novel Sertoli and Leydig Cell-specific Transcripts
To identify novel Sertoli and Leydig cell-specific transcripts we performed microarray analysis using equivalent amounts of total RNA extracted from immunoprecipitates (IPs) and inputs from AMH-Cre: RiboTag or Cyp17iCre:RiboTag mouse testis, respectively. In AMH-Cre: RiboTag mouse testis, the IP fraction was highly enriched in Sertoli cell-specific transcripts such as Transferrin (Tfr), follicle-stimulating hormone receptor (Fshr) and Poliovirus receptor (Pvr); while it was significantly de-enriched in Leydig and germ cell-specific transcripts such as the LH receptor (Lhcgr), steroidogenic acute regulatory protein (Star), Protamine 1 and 2 (Prm1 and Prm2) (Fig. 1C). Using the enrichment data we generated a list of the top 50 Sertoli cell-specific genes (Table S1; a complete list of all genes with fold enrichment ≥2 is shown in Dataset S1). Among these enriched genes, we could identify novel Sertoli cell-specific transcripts coding for receptors, such as the Mannose receptor Mrc1, the Vitamin D receptor (Vdr), the inositol triphosphate receptor Itpr2 or the G-protein coupled receptor Gpr37 (Fig. 2A), or enzymes such as Calpain 6 (Capn6), the phophodiesterase/phospholipase Enpp2 or the arachidonate lipooxygenase Alox12, among others (Fig. 2B). Gene ontology (GO) analysis of Sertoli cell-specific or highly enriched transcripts (those that showed a 5-fold or higher IP/input ratio) identified several overrepresented GO categories (Table S2), such as regulation of cellular compartment movement or regulation of cell migration, consistent with the active involvement of Sertoli cells in the process of migration and differentiation of spermatogonial stem cells from the basal to the adluminal compartment, and cytoskeletal protein and actin binding, which included several transcripts that code for components of the highly specialized structures found in Sertoli cells called ectoplasmic specializations. Furthermore, GO analysis identified a significant enrichment for transcripts involved in sex determination, GTPase regulatory activity, formate-tetrahydrofolate ligase activity and phosphodiesterase 1 activity, pointing to potential novel functions in Sertoli cells.
Microarray analysis data showing the top ten receptors (A) and enzymes (B) with the highest enrichment in Sertoli and Leydig cells. The enrichment value was calculated as the ratio of the signal in the IPs to their inputs.
Similar analysis in Cyp17iCre: RiboTag testis demonstrated enrichment for well-known Leydig cell specific transcripts such as the LH receptor (Lhcgr) and Star, among others, while germ cell-specific transcripts showed de-enrichment (IP/Input ratio <1; Fig. 1D). Unexpectedly, Sertoli cell transcripts did not show negative enrichment, suggesting that the scattered HA-positive cells observed within the tubule are Sertoli cells, underscoring the high sensitivity of the RiboTag approach (Fig. 1D, and A, arrows). However, while most of the Sertoli cell-specific transcripts found showed an IP/input ratio of 1–1.7, Leydig cell-specific transcripts were enriched 7-fold or greater, allowing us to identify cell-specific/highly-enriched Leydig cell transcripts. The IP/input ratio analysis in Cyp17iCre: RiboTag testis identified the top 50 Leydig cell-specific (or highly enriched) transcripts (Table S3, complete table of enriched genes is available in Dataset S2); these enriched transcripts included novel receptors such as the IL17 receptor Il17br, the G-protein coupled receptor Gpr128, the interferon receptor Ifnar2, and the low density lipoprotein receptor (ldlr), among others (Fig. 2A). We also identified novel Leydig cell-specific enzymes such as the carboxylesterase Ces3, Fetuin-beta (Fetub), the paraoxonase Pon3 and the kallikrein-related peptidase Klk1b22 (Fig. 2B). Of note, other transcripts of the kallikrein family of serine proteases or the related family of serine protease inhibitors, the serpins, also showed significant enrichment (Table S4). While several members of the kallikrein family have been reported as Leydig cell-specific , , , the kallikrein family member that showed the highest enrichment in our RiboTag experiments, Klk1b22, had not been previously identified in Leydig cells. GO analysis of the Leydig enriched transcripts (7-fold or higher) revealed highly significant molecular function and biological process categories related to steroidogenesis (Table S5), such as lipid, alcohol, cellular ketone and organic acid metabolic processes, oxidoreductase activity, steroid dehydrogenase activity and steroid and coenzyme binding, confirming the highly specialized nature of this cell type in the testis. Two transcripts (Spnb1 and Etl4) showed artifactual enrichment in both Cyp17iCre: RiboTag and AMH-Cre: RiboTag IPs, suggesting non-specific IP of these transcripts perhaps due to anti-HA antibody binding to nascent chains coded by these two mRNAs or some other type of non-specific interaction.
Regulation of Sertoli Cell Transcripts by Testosterone (T) and FSH
To characterize the transcripts regulated by T or FSH in the polysomes of Sertoli cells, AMH-Cre: RiboTag mice were treated with the GnRH antagonists cetrorelix or acyline every 24 h for 3 days prior to T or FSH administration (Text S1). Both GnRH antagonists suppressed T and greatly reduced FSH levels in serum (Fig. S2A and Fig. S3A). However, microarray analysis of the polysome-associated mRNAs after gonadotropin depletion with these two different GnRH antagonists resulted in only minor changes when compared to the effects of gonadotropin withdrawal in Leydig cells (Fig. S1). Administration of testosterone enanthate or highly purified FSH restored the circulating levels of these two hormones (Fig. S2A and Fig. S3A), but only modest effects on Sertoli-enriched genes were seen in both cases (Fig. S2B and Fig. S3B–C). Few genes were regulated after 4 h of T, and only two, Slc15a1 and Kazald1, were highly enriched in Sertoli cells (Fig. S2C and Fig. S2D). These two transcripts along with two other Sertoli cell enriched transcripts that showed increased polysome association after T stimulation were further confirmed by qRT-PCR analysis (Fig. S2D).
We assayed changes in FSH induced mRNA association with Sertoli cell polysomes at 1 hr to detect rapid effects on translation and induction of immediate early genes. Messenger RNA changes at 4 hr after FSH were assayed to capture more slowly induced changes and to allow comparison with previously published data in hypogonadal mice after 4 hr of FSH stimulation . After 1 h of FSH stimulation, none of the upregulated transcripts were Sertoli cell enriched, suggesting that these transcripts are either not expressed or expressed at very low levels in Sertoli cells (Fig. S3B). Transcripts enriched in Sertoli cells, such as Eomes, Reln and Chst2, among others, showed decreased polysome association after 1 h of FSH (Fig. S3B and D). After 4 h of FSH, the transcript response in Sertoli cells was minor and only 9 Sertoli-enriched transcripts showed changes greater than 1.5 fold in the immunoprecipitated polysome fraction (Fig. S3C and E).
Early Leydig Cell mRNA Profile after LH Restoration
To identify novel transcripts involved in the response of Leydig cells to LH in vivo, Cyp17iCre: RiboTag mice were treated as described in Fig. 3A. Mice received a subcutaneous injection of the GnRH antagonist acyline every 24 h for 4 days, followed by a single intraperitoneal injection of purified LH (2 units) 2 h after the last acyline injection. To characterize the transcripts involved in the immediate-early, and the intermediate-late response to LH, mice were sacrificed at 1 h and 4 h after LH administration. Repeated injections of acyline completely abolished LH and T serum levels, and reduced FSH levels by 84% (Fig. 3B–D). As expected, a single injection of LH (2 units) significantly increased LH and T serum levels (Fig. 3B and C), but did not increase FSH serum levels (Fig. 3D), confirming the lack of significant FSH contamination in the LH preparation.
Experimental design is shown in panel (A). Cyp17iCre: RiboTag mice were injected with the GnRH antagonist acyline (300 ug) for 4 d before a single intraperitoneal injection of LH (2 units). Mice were sacrificed at 1 h and 4 h post-injection and serum levels of LH (B), T (C) and FSH (D) were determined by RIA or EIA (n = 4, from two independent experiments). Graphs show the mean ± SEM. Statistical analysis was performed using One-way Analysis of Variance (ANOVA) with Newman-Keuls multiple comparison post-hoc test. *** p<0.001, ** p<0.01, * p<0.05 vs acyline, ### p<0.001 vs saline. Dashed line in (B) shows the lower reportable limit. All acyline samples were below this limit. (E) Hierarchical clustering of the microarray data. Samples were clustered using all genes present in at least one sample. The y-axis represents the correlation distance (1-R) between each pair of samples at the nearest branch point between the two samples. Note that all samples from the same treatment group together.
After treatments, the HA-tagged polysomes were recovered and microarray analysis performed. Hierarchical clustering of Affymetrix array data from all treatment groups correctly distinguished individual groups based upon their gene expression profiles, providing additional confidence in the experimental paradigm (Fig. 3E). Comparison of IP pellets from acyline treated versus 1 hr LH treated samples revealed 71 specific mRNAs with altered ribosome association at this time point, with most of the transcripts being increased (Fig. 4A–B, transcripts with a 2-fold or higher increase after 1 h of LH administration are shown in Fig. S4A). A subsequent enrichment analysis (IP/input ratio in saline-treated animals) identified those transcripts enriched in Leydig cells (Fig. S4B). None of the transcripts positively regulated by LH are Leydig cell-specific (Enrichment >7). GO analysis of the transcripts with a 1.5 or higher fold change identified transcription factor activity and cell cycle as two of the top overrepresented categories (Fig. 4C and D). One particular group of transcription factors showed a dramatic increase in ribosome association after 1 h of LH stimulation, returning to basal levels at 4 h of LH stimulation (Fig. 4C). Two of the most strongly induced factors, Nr4a1 and Egr1, were validated by qRT-PCR analysis (Fig. 4E–F). Enrichment analysis indicated that Nr4a1 and Egr1 transcripts were either de-enriched (IP/input <1), or not enriched (IP/input ~1) in control (saline treated) Leydig cells, respectively, but strongly induced in Leydig cells after 1 h of LH treatment, which is reflected in the increased enrichment ratio in 1 h LH samples (Fig. 4E–F). This is the expected result for genes that are expressed in multiple cell types in the testis but are LH regulated in Leydig cells (a more detailed enrichment analysis is illustrated in Fig. S5). Regarding the cell cycle GO category, Rgs2 was identified as an interesting candidate because of its potential involvement in regulating the LH receptor. IP versus input analysis revealed that Rgs2 was the only transcript of the Rgs family significantly enriched in Leydig cells (Fig. S6A). Furthermore, qRT-PCR analysis of the IP fractions after acyline and LH treatment also confirmed that Rgs2 levels were decreased by acyline, and that LH stimulation for 1 h significantly increased Rgs2 transcript association with ribosomes. Enrichment ratios (IP/input) in acyline and 1 h LH samples also indicated that the increase in Rgs2 was specific to Leydig cells, as the enrichment ratio increased in the 1 h LH sample and decreased in the acyline samples (Fig. 4G).
(A) Cartoon shows the two experimental groups compared by microarray analysis. (B) Venn diagrams showing the number of mRNAs regulated after 1 h of LH administration (1.5 fold or higher) when compared to the acyline group in the IPs of Cyp17iCre: RiboTag mice by microarray analysis. Values in the intersection are the number of transcripts regulated by LH and enriched (IP/input >2 in untreated mice) in Leydig cells. GO analysis was performed on the transcripts that showed a fold increase of 1.5 or higher after 1 h of LH stimulation. Transcription factor activity (C) and cell cycle (D) were identified as significant categories. Heat maps show the regulation by microarray analysis of the transcripts included in these GO categories. AdjP: Adjusted p-value. Some transcripts (shown in red) were further confirmed by qRT-PCR because of their novelty or significance (E–F and G). Graphs show qRT-PCR confirmation for Nr4a1, Egr1 (E–F) and Rgs2 (G) in the IPs of Cyp17iCre: RiboTag mice treated with saline, acyline, acyline+LH for 1 h and acyline+LH for 4 h (n = 4, from two independent experiments). Statistical analysis was performed using One-way Analysis of Variance (ANOVA) with Newman-Keuls multiple comparison post-hoc test. *** p<0.001, ** p<0.01 and * p<0.05 vs acyline. IP versus input ratio (Enrichment) was assessed by qRT-PCR and shows the abundance of the transcript in Leydig cells. Data are the mean±SEM.
Late Leydig Cell mRNA Profile after LH Restoration
Microarray analysis of transcripts associated with HA-tagged polysomes in Cyp17iCre: RiboTag mice testis after 4 h of LH stimulation compared to those treated with acyline revealed 351 regulated mRNAs (Fig. 5A–B, transcripts with a 2 fold or higher increase after LH stimulation are shown in Fig. S7A). Some of them were also identified as highly enriched in Leydig cells (Fig. S7B). Consistent with the known physiological role of Leydig cells, GO analysis of the transcripts with increased ribosome association (1.5 fold or higher) revealed that steroidogenesis-related categories were overrepresented (Fig. 5C). Our results confirmed previously described transcripts, such as Star, Cyp11a1 and Scarb1, but also revealed that the Star-related transcript Stard5 is regulated by LH. Acyline treatment significantly reduced the ribosome-association of Stard5, which then increased significantly with 4 h of LH treatment. qRT-PCR analysis confirmed the microarray results (Fig. 5D). Enrichment analysis by microarray showed that Star (also known as Stard1), Stard4 and Stard5 were the only transcripts in the Stard family that showed a significant enrichment in the IP when compared to their inputs (Fig. S6B). The enrichment for Stard5 in Leydig cells was further confirmed by qRT-PCR (Fig. 5D legend).
(A) Cartoon showing the two experimental groups compared by the microarray analysis. (B) Venn diagrams showing the number of mRNAs regulated in the IPs of Cyp17iCre: RiboTag mice after 4 h of LH administration (1.5 fold or higher) when compared to the acyline group by microarray analysis. Values in the intersection are the number of transcripts regulated by LH and enriched (IP/input >2 in untreated mice) in Leydig cells. GO analysis was performed on the transcripts that showed a fold increase of 1.5 or higher after 4 h of LH stimulation. Steroid metabolic process (C), carboxylic acid transmembrane transporter activity (E), FGF receptor activity (G) and transcription repressor activity (J) were identified as significant GO categories. Heat maps show the regulation by microarray analysis of the transcripts included in these GO categories. AdjP: Adjusted p-value. Some transcripts (shown in red) were further confirmed by qRT-PCR because of their novelty or significance (D, F, H–I and K–L). Graphs show qRT-PCR confirmation for Stard5 (D), Slc16a3 (F), Fgfr4, Fgfr2 (H–I), Tbx2 and Tbx3 (K–L) in the IPs of Cyp17iCre: RiboTag mice testis treated with saline, acyline, acyline+LH for 1 h and acyline+LH for 4 h (n = 4, from two independent experiments). Statistical analysis was performed using One-way Analysis of Variance (ANOVA) with Newman-Keuls multiple comparison post-hoc test. ### p<0.001, # p<0.05 vs saline; *** p<0.001, ** p<0.01, * p<0.05 vs acyline. Enrichment (IP versus input ratio) for the analyzed transcripts in saline-treated animals by qRT-PCR analysis was the following: 17.4±1.3 for Slc16a3, 21.6±2.3 for Star, 9.8±1.3 for Stard5, 8.0±0.7 for Scarb1, 12.0±1.2 for Fgfr2, 15.9±1.2 for Fgfr4, 4.1±0.9 for Tbx2, and 13.3±1.6 for Tbx3. Data are the mean±SEM.
Importantly, our approach allowed us to identify novel overrepresented categories after 4 h of LH exposure such as carboxylic acid transmembrane transporter activity and FGF receptor activity (Fig. 5E and G). Most of the transcripts related to carboxylic acid transmembrane transporter activity were amino acid transporters (Slc7a1, Slc38a1, Slc7a11, Slc1a4), yet the most prominent was the lactic acid and pyruvate proton-linked transporter Slc16a3 (monocarboxylic acid transporter 4; MCT4). Slc16a3 was also significantly enriched in the IPs as assessed by microarray and qRT-PCR analysis (Fig. 5F legend and Fig. S6C). qRT-PCR analysis confirmed that the ribosome-association of this transcript was reduced after acyline treatment and dramatically increased after 4 h of LH treatment (Fig. 5F). In addition, two members of the FGF receptor activity family transcripts (Fgfr4, Fgfr2) showed increased ribosome-association in the microarray analysis after 4 h of LH treatment (Fig. 5G) and were significantly enriched in Leydig cell polysomes (Fig. S6D). qRT-PCR analysis confirmed these results (Fig. 5H–I). Finally, transcripts involved in the negative regulation of adenylate cyclase activity were also induced after 4 h of LH, which included the sphingosine-1-phosphate (S1P) receptors S1pr1 and S1pr3 (Fig. S7C), suggesting a possible role of S1P in the modulation of LH signaling in Leydig cells.
Negative Regulation of Leydig Cell Transcripts after LH Administration
LH administration also resulted in decreased ribosome-association of a group of mRNAs which was more evident after 4 h of LH treatment compared with 1 h LH (Fig. 4B and 5B) and included novel Leydig cell-specific (or highly enriched) transcripts (Fig. S7B). mRNAs that showed a 2-fold or greater decrease after 4 h of LH administration are listed in Fig. S7E. Among them, Fetub was confirmed by qRT-PCR to be highly specific to Leydig cells and significantly reduced after LH treatment (Fig. S7D).
Transcriptional repressor activity was among the most significant GO categories of transcripts that were reduced after 4 h of LH (Fig. 5J). Tbx2 and Tbx3 were two transcripts with transcription repressor activity that responded robustly to acyline and LH. qRT-PCR analysis confirmed that acyline significantly increased the ribosome-association of Tbx2 and Tbx3, which was reversed with 1 h of LH treatment for Tbx3 and 4 h of LH treatment for Tbx2 (Fig. 5K–L). qRT-PCR results also confirmed that these transcripts were significantly enriched in Leydig cells (Fig. 5K–L, legend) and similar analysis using the microarray data showed that these transcripts were the only Tbx family members that showed a significant enrichment in Leydig cells (Fig. S6E). Another significant GO category of transcripts with decreased polysome-association after 4 h of LH stimulation included those with ligand-dependent nuclear receptor activity, and contained the thyroid hormone receptor Thrb, the Rev-Erb receptors Nr1d1 and Nr1d2, and the orphan receptor Nr0b2 (Fig. S7F). These nuclear receptors are also known to act as transcriptional repressors.
Regulation of Aquaporin 2 by LH in Leydig Cells
Microarray analysis of transcripts associated with the HA-tagged polysomes in Leydig cells revealed that aquaporin 2 (Aqp2) was strongly regulated by acyline and LH treatment. Under basal conditions, Aqp2 showed a high enrichment in Leydig cells (Fig. 6A legend); however, the enrichment was not equivalent to the most Leydig-cell specific transcripts, suggesting that Aqp2 was also expressed in other cell types of the testis. The microarray results were confirmed by qRT-PCR analysis, western blot of total testis protein lysates and immunohistochemistry using an anti-aquaporin 2-specific antibody (Fig. 6A–C). Immunohistochemistry also revealed staining in the central region of some seminiferous tubules, consistent with our results suggesting that Aqp2 mRNA was highly enriched but not specific to Leydig cells. We confirmed Aqp2 expression and regulation by LH in the MA-10 Leydig cell line. LH treatment induced a 120-fold increase in Aqp2 mRNA after 2 h of LH, which was sustained after 4 h and 8 h of LH treatment (Fig. 6D). This increase in Aqp2 mRNA was directly correlated with a dramatic increase in aquaporin 2 protein (Fig. 6E). Our data supports a direct regulation of this water channel by LH. In addition, microarray analysis revealed that Aqp2 was the only member of the aquaporin family that showed a significant enrichment in Leydig cells (Fig. S6F). These results suggest that Leydig cells may be regulating water transport by an LH/cAMP dependent signaling pathway similar to that observed in the vasopressin-dependent epithelial cells of the kidney collecting ducts. The biological role of this transport in Leydig cell function is unknown.
(A) qRT-PCR analysis of Aqp2 mRNA in the IPs of Cyp17iCre: RiboTag mice treated with saline, acyline, acyline+LH for 1 h and acyline+LH for 4 h (n = 4, from two independent experiments). Statistical analysis was performed using One-way Analysis of Variance (ANOVA) with Newman-Keuls multiple comparison post-hoc test. # p<0.05 vs saline; *** p<0.001 vs acyline. Enrichment (IP versus input ratio) for Aqp2 in saline-treated animals was 17.9±1.7 by qRT-PCR analysis. Data are the mean±SEM. (B) Western blot analysis of aquaporin 2 in testis lysates of mice treated with saline, acyline, acyline+LH for 1 h and acyline+LH for 4 h. Membrane was reprobed with an anti-beta-actin antibody to confirm equal loading of the samples. (C) Immunohistochemistry for aquaporin 2 in testis sections of mice treated with saline, acyline and acyline+LH for 4 h. Black arrows show staining in Leydig cells and white arrows show staining in germ cells. (D) qRT-PCR analysis of Aqp2 mRNA in MA-10 cells after LH stimulation (0.2 u/ml). Statistical analysis was performed using One-way Analysis of Variance (ANOVA) with Newman-Keuls multiple comparison post-hoc test. *** p<0.001 vs 0 h. (E) Western blot analysis of aquaporin 2 in MA-10 cell lysates after LH exposure (0.2 u/ml) for different time points.
LH Increases the Polysome-association of Ribosomal Protein Transcripts
Cluster analysis of the microarray data from the IPs (Text S1) showed an important cohort of transcripts whose polysome-association was increased after 1 h and 4 h of LH administration (Fig. S8A). In addition to several mRNAs coding for elongation and initiation factors, 62% of the probes in this cluster were for ribosomal protein transcripts (Fig. 7A and B). One of these mRNAs, Rps8, was further confirmed by qRT-PCR (Fig. S8B). This increased presence of ribosomal protein mRNAs in the IPs correlated with an increased phosphorylation of the ribosomal protein S6 at Ser235/236. Western blot analysis of testis lysates showed a decrease in the phosphorylation of the ribosomal protein S6 after acyline treatment, and a dramatic increase after 1 h of LH treatment that was sustained at 4 h (Fig. 7C). Immunohistochemical analysis localized these changes to the Leydig cell compartment in the interstitial space (Fig. 7D).
(A) Microarray cluster containing the probes that showed increased polysome-association in Cyp17iCre: RiboTag mice after 1 h and 4 h of LH administration. All ribosomal proteins and elongation/initiation factors present in the cluster are listed. Statistical analysis was performed using One-way Analysis of Variance (ANOVA) with Newman-Keuls multiple comparison post-hoc test (p<0.01 vs acyline). (B) Pie chart representing the percentage of probes for ribosomal proteins contained in (A). (C) Western blot analysis of phospho-S6 (S235/236) levels in testis lysates after acyline and LH treatment (D) Immunohistochemistry for phospho-S6 ribosomal protein (Ser 235/236) in testis sections of saline, acyline, or acyline+LH-treated mice. Arrows point to the interstitial spaces, where Leydig cells are located. (E) Representative polysome profiles of untreated, LH-treated or rapamycin+LH-treated MA-10 cells. Fractions 1–3 contain the cytosolic fraction, 4–5 the monosome fraction, and fractions 6–12 contain the polysome fraction. Cells were serum-starved overnight and treated for 30 min with Rapamycin (20 nM) or vehicle prior to the addition of LH (0.2 u/ml) for 1 h.
We hypothesized that this increased polysome association of mRNAs coding for components of the translational machinery was in response to a stimulatory effect of LH on the translational activity of Leydig cells, and that this effect was mediated by mTOR, as suggested by the increased phosphorylation of S6. To confirm this hypothesis, we assessed the translational status of MA-10 cells after LH stimulation, with or without the addition of the mTOR inhibitor rapamycin (Fig. 7E). Polysome profiling analysis of MA-10 cells after LH treatment revealed a decrease in the monosome peak (fractions 4 and 5) with a concomitant increase in the abundance of heavy polysomes (fractions 9–12), consistent with an increased rate of translation initiation. Rapamycin pretreatment prevented the LH effect on the polysome profile confirming the involvement of mTOR signaling in this process. The inhibitory effect of rapamycin on mTOR activity was confirmed by Western blot analysis of phospho-S6 in the lysates (Fig. S8C).
A variety of strategies have been used previously to identify mRNA transcripts specific to somatic cell types in the testis, but these have required purification of Leydig or Sertoli cells using several days of cell culture in conjunction with in silico subtraction methods to establish cell-type specific transcripts . Although these approaches have provided valuable insight into testicular biology, they depend upon cell culture techniques that can substantially affect gene expression over several days and are not well adapted to multiple measurements during hormonal regulation. In this paper we have used Cre Driver mice to express tagged ribosomes in either Sertoli or Leydig cells and then directly isolate actively translated mRNAs by polysome immunoprecipitation. Hence, we provide a unique approach to isolate transcripts directly from the complex three-dimensional environment of the testis giving us a snapshot of the translatome in a specific cell type in vivo.
RiboTag analysis of AMH-Cre or Cyp17iCre driven cell transcriptomes by enrichment ratio (IP/input) clearly delineated the transcripts specific to Sertoli or Leydig cells, respectively. Enrichment for classical markers was achieved along with identification of previously unidentified cell-specific receptors and enzymes, which will help shed light on the biology of these cell types. In Sertoli cells, the mannose receptor Mrc1 was one of the novel cell-specific (or highly enriched) receptors described. Although the role of this receptor in Sertoli cells is currently unknown, one of its ligands, the extracellular protease tPA (tissue plasminogen activator, Plat) ,  is also Sertoli -cell- specific according to our enrichment analysis. In the testis, the plasminogen activator system is thought to be involved in the degradation of components of the extracellular matrix for the remodeling of the seminiferous tubule during spermatogenesis , . Therefore, MRC1 may bind tPA to concentrate its activity in the immediate environment of the Sertoli cell, or participate in the clearance of this protease from the extracellular space . In Leydig cells, enrichment analysis also uncovered new potential targets for the regulation of Leydig cell function by identifying novel cell-specific receptors and enzymes. The scattered Cre-expressing cells in the Cyp17iCre: RiboTag mice that were visualized within the tubule by immunohistochemistry could be identified as Sertoli cells by the mRNA enrichment experiments.
Gene Ontology (GO) analysis of genes enriched in Sertoli and Leydig cells confirmed some well-known functions of these cell types, including regulation of sex determination and the unique actin-containing structures known as ectoplasmic specializations in Sertoli cells , , , and steroid biosynthetic categories in the Leydig cells. However, additional GO categories suggest potential novel biological functions and novel players within these unique cell types. Interestingly, GO analysis in Sertoli cell-enriched genes yielded less statistically robust categories than Leydig-enriched genes, which may be indicative of the more complex cellular role of Sertoli cells in supporting the development of the spermatogonia to become spermatocytes, spermatids and finally mature spermatozoa.
Sertoli cell gene regulation was examined by shutting off endogenous GnRH driven gonadotropin secretion using GnRH receptor antagonists (acyline or cetrorelix) prior to administration of either testosterone (T) or FSH. Analysis of the Sertoli cell ribosome-associated mRNA profile after gonadotropin deprivation demonstrated relatively modest changes and consistent with this, the administration of T or FSH to gonadotropin depleted mice produced changes in only a small number of polysome-associated mRNAs that were Sertoli cell enriched. Among them, we confirmed the regulation of the phosphodiesterase, PDE4D, by FSH as previously described , . The modest response of Sertoli cell mRNAs to GnRH antagonists may be due to the residual levels of FSH that remained after antagonist treatment. However, these results suggest that Sertoli cells are not acutely dependent on FSH in contrast to the rapid response of Leydig cells to LH and are consistent with the observation that LH, but not FSH, is essential for fertility in male mice , .
In contrast to the modest response of Sertoli cell genes to hormonal manipulations, Leydig cell-enriched transcripts responded dramatically to LH. LH stimulation for 1 h induced immediate-early transcription factor activity including Nr4a1, Junb, Jun, Fos and Myc, in agreement with previous results , . In addition we discovered that Egr1 mRNA is strongly induced by LH at this time point. Further analysis of transcripts showing an early response to LH revealed novel candidates for downstream cell signaling such as the regulator of G protein signaling 2 (Rgs2), which was induced at 1 h and then returned to baseline at 4 h. G protein-coupled receptors (GPCRs) such as the LH/CG receptor (Lhcgr) are negatively regulated by the RGS family and previous reports identified RGS2 as an attenuator of G protein activity during LH receptor signaling in granulosa cells of the ovary , . Our results suggest that RGS2 may have similar actions in the Leydig cell. In addition, the fast and transient association of this transcript with polysomes (within 1 h of LH stimulation) is consistent with a role in the regulation of receptor signaling.
Regulation of transcripts involved in steroid metabolism occurred at the later time point (4 h), which suggests that the burst of immediate early gene expression seen at 1 h may be required for subsequent induction of genes involved in steroid biosynthesis at 4 h. Our results confirmed the regulation of several mRNAs involved in the transport and uptake of cholesterol, such as Star and Scarb1, but, more interestingly, our data revealed that Star is not the only START (StAR-related lipid transfer) domain-containing gene to be regulated by LH. Stard5, another START-containing transcript, is also enriched in Leydig cells and regulated by LH. It has been proposed that StarD5 may act as a soluble cholesterol transporter shuttling cholesterol from intracellular stores to various membranes such as the plasma membrane or the endoplasmic reticulum (ER) . Thus, in the Leydig cell, StarD5 may be mediating intracellular trafficking of cholesterol. Our results showing that acyline decreases and LH restores Stard5 transcripts in Leydig cells differs from results using MA-10 cells . Other studies using the Leydig cell tumor line, MA-10, have not always been in agreement with in vivo or primary cell culture studies ,  highlighting the importance of using in vivo physiological approaches.
The Fibroblast Growth Factor (FGF) family of ligands and its receptors are another category of signaling molecules that play important roles in development of the primitive gonad but also appear to have roles in the fetal, immature and adult testis , , . Our results demonstrate that in adult Leydig cells, LH signaling is required for the maintenance of Fgfr2 and Fgfr4 expression. It has been suggested (using cell culture systems) that FGF signaling in adult and fetal Leydig cells is only responsible for LH-independent steroidogenesis, with no effects on LH/hCG-directed steroid synthesis , . Our results suggest that in a physiological environment, FGF signaling via FGFR2 and FGFR4 may be responsive to LH levels.
We have also described the transcripts that undergo negative regulation after LH stimulation. The T-box transcription factors Tbx2 and Tbx3 showed increased polysome association when gonadotropin tone was reduced with acyline, and decreased again when LH was restored. Tbx2 is highly expressed in P0 testis in the interstitium compartment and then decreases below detection at P14 as measured by immunohistochemistry . Leydig cells are a major cell component of the interstitium and our more sensitive mRNA assays demonstrate that both Tbx2 and Tbx3 continue to be expressed in adult Leydig cells where they are repressed by the presence of LH. The role of Tbx2 or Tbx3 in adult male gonads is unknown since knockout of these genes results in embryonic lethality , , .
Our results have also uncovered specific regulation of the water channel, AQP2, by LH in the Leydig cell. In contrast to a previous study suggesting that Aqp2 transcripts were restricted to germ cells of the mouse testis , our data revealed that Aqp2 transcripts are in fact highly enriched in Leydig cells and dramatically regulated by LH. This discrepancy may be explained by the indirect method of assessing Aqp2 expression using a transgenic mouse with a modified Cre recombinase cassette expressed under the control of a 14 kb fragment of the human Aqp2 promoter . Although the biological significance of AQP2 expression in Leydig cells is unknown, it is well established that Leydig cells have a prominent role in the regulation of the interstitial fluid volume and hCG has been to shown to directly regulate interstitial fluid volume through its actions on these cells , . It is also possible that the role of AQP2 in Leydig cells may be cell-autonomous and related to intracellular changes in fluid dynamics in the Leydig cell as these cells become metabolically more active and are synthesizing steroids.
Finally, our results also provide evidence for LH-dependent regulation of the translational apparatus and thus protein synthesis in Leydig cells. The increased ribosome association of a large number of ribosomal protein transcripts as well as several elongation and initiation factor transcripts after LH stimulation suggests a potent stimulatory effect of LH on the translational machinery of the Leydig cell. This increased ribosome association of components of the translational apparatus appears to be mTOR-dependent in agreement with previous reports describing the regulation of protein synthesis by mTOR functioning within the mTORC1 complex . Messenger RNAs coding for ribosomal proteins and elongation/initiation factors are characterized by the presence a 5′ terminal oligopyrimidine tract (referred to as 5′TOP mRNAs) and these transcripts have recently been confirmed to be regulated by mTORC1 at the translational level , although there are conflicting results . Our results demonstrate that LH induces the activation of mTOR in vivo as assessed by the phosphorylation of the ribosomal protein S6, which correlates with an increased ribosome-association of 5′TOP mRNAs. Although S6 phosphorylation is a reliable marker for mTOR activity, this phosphorylation is not responsible for the translational efficiency of 5′TOP mRNAs , , as originally thought . Since ribosomal proteins transcripts are regulated at the translational level in higher eukaryotes , , , the RiboTag mouse model is uniquely suited to the identification of this type of regulation.
Much of the future work to be carried out in biomedical research will rely on technology that provides cell-type-specific resolution combined with genome-scale analysis of gene expression changes occurring in unique cell types in physiologically meaningful contexts , , . Toward that end, we have used the RiboTag mouse model combined with microarray analysis to analyze the translatome in two critical somatic cell types of the testis, the Sertoli and Leydig cells, in a paradigm where the hormonal milieu has been fundamentally altered. We have demonstrated the advantages of the technique in allowing rapid enrichment of translated mRNAs specific to each cell type and the application of this technique to detect dynamic changes in the association of particular transcripts with the translational machinery during physiological regulation in the in vivo setting.
Sertoli and Leydig cell response to gonadotropin deprivation. Venn diagrams showing the number of transcripts with increased or decreased polysome association (1.5 fold or higher) after treatment with the GnRH antagonists cetrorelix (A) or acyline (B) in AMH-Cre: RiboTag mice, or with acyline in Cyp17iCre: RiboTag mice (C) by microarray analysis. The number of transcripts regulated by GnRH antagonist administration and enriched (IP/input >2 in untreated mice) in the cell type of interest is shown in the intersection.
In vivo Sertoli-cell translational profile after testosterone (T) administration. (A) T and FSH serum levels in AMH-Cre: RiboTag mice treated with saline, Cetrorelix or Cetrorelix+testosterone (T) (n = 3). Cetrorelix (50 ug) was given s.c. for 3 d before a single i.p. injection of testosterone enanthate (10 mg). Serum was obtained 4 h after the T administration. (B) Venn diagram showing the number of transcripts regulated after T administration (1.5 fold or higher) when compared to the Cetrorelix group by microarray analysis. Values in the intersection are the number of transcripts regulated by T and enriched (IP/input >2 in untreated mice) in Sertoli cells. Table (C) lists these transcripts with their respective fold change and enrichment values. (D) qRT-PCR confirmation of microarray results (n = 3). Enrichment by qRT-PCR was 2.3±0.2 for Pyroxd2, 5.8±0.5 for Kazald1, 8.0±0.5 for Slc15a1 and 1.5±0.1 for Myof. Data are the mean±SEM. Statistical analysis was performed using One-way Analysis of Variance (ANOVA) with Newman-Keuls multiple comparison post-hoc test. ### p<0.001, ## p<0.01 and # p<0.05 vs saline; *** p<0.001, and * p<0.05 vs acyline.
Sertoli cell translational profile after FSH administration. (A) Serum levels for FSH and T after acyline and FSH administration (n = 3). Acyline was given for 3 d before FSH (1 u) administration for 1 h and 4 h. Data are the mean±SEM. Statistical analysis was performed using One-way Analysis of Variance (ANOVA) with Newman-Keuls multiple comparison post-hoc test. ## p<0.01 vs saline and *** p<0.001 vs acyline. (B–C) Venn diagrams showing the number of transcripts regulated after 1 h or 4 h of FSH administration (1.5 fold or higher) when compared to the acyline group by microarray analysis. Values in the intersection are the number of transcripts regulated by FSH and enriched (IP/input >2 in untreated mice) in Sertoli cells. Tables (D–E) list these transcripts with their respective fold change and enrichment values.
Leydig cell translational profile after 1 h of LH administration. (A) Heat map showing the regulation of transcripts with a 2-fold or higher increase after 1 h of LH stimulation (versus acyline treatment) in the Cyp17iCre: RiboTag IPs by microarray analysis. Only two transcripts (Bcl6 and Dppa4) showed a two-fold or greater decrease after LH stimulation. Table (B) lists the Leydig-cell enriched mRNAs (2-fold or higher under basal conditions) that showed a 1.5 or higher fold change after 1 h of LH administration.
qRT-PCR analysis of transcripts expressed at different levels in Leydig cells using inputs and IPs from Cyp17iCre: RiboTag mice. Mice were treated with saline, acyline, acyline+LH for 1 h and acyline+LH for 4 h (n = 4, from two independent experiments). Notice that analysis of the IP fraction allows for the detection of LH-induced changes in transcripts with low expression in Leydig cells (when compared to other cell types in the testis), and results in higher signal and more statistical significance for the transcripts that are enriched or specific to the targeted cell type. Data are the mean±SEM. Statistical analysis was performed separately for each group (inputs or IPs) using One-way Analysis of Variance (ANOVA) with Newman-Keuls multiple comparison post-hoc test. ### p<0.001, # p<0.05 vs saline; *** p<0.001, ** p<0.01, * p<0.05 vs acyline.
Enrichment analysis. Microarray analysis data of different transcripts from the Rgs (A), Stard (B), MCT (C), Fgfr (D), Tbx (E) and Aqp (F) family presented as fold change in the IPs versus the inputs (Enrichment) in untreated Cyp17iCre: RiboTag mice (n = 3). Data are the mean±SEM.
Leydig cell translational profile after 4 h of LH administration. (A) Heat map showing the regulation of transcripts with a 2-fold or higher increase after 4 h of LH administration (versus acyline treatment) in the Cyp17iCre: RiboTag IPs by microarray analysis. (B) Table shows the Leydig cell-specific (or highly enriched) transcripts (6-fold or higher under basal conditions) that showed a 1.5 or higher fold change after 4 h of LH stimulation. (C) Heat map showing the regulation of the sphingosine-1-phosphate receptors S1pr1 and S1pr3 by microarray analysis in Cyp17iCre: RiboTag mice IPs after treatment with saline, acyline, acyline+LH for 1 h and acyline+LH for 4 h. (D) qRT-PCR confirmation of microarray results for Fetub in IPs from Cyp17iCre: RiboTag mice treated with saline, acyline, acyline+LH for 1 h and acyline+LH for 4 h (n = 4, from two independent experiments). Statistical analysis was performed using One-way Analysis of Variance (ANOVA) with Newman-Keuls multiple comparison post-hoc test. ** p<0.01 vs acyline. Enrichment (IP versus input ratio) by qRT-PCR analysis for Fetub in saline-treated animals was in the Leydig cell-specific range (20.8±2.7). (E) Heat map of transcripts that show a 2-fold or greater decrease after 4 h of LH (versus acyline treatment) in the Cyp17iCre: RiboTag IPs by microarray analysis. (F) Heat map showing the regulation of transcripts involved in ligand-dependent nuclear receptor activity.
Cluster analysis, Rps8 confirmation and phospho-S6 levels. (A) Cluster analysis of the microarray data obtained from IPs of Cyp17iCre: RiboTag mice treated as described. Transcripts that were significantly different between groups (p<0.01 using One-way Analysis of Variance (ANOVA)) were grouped into different clusters according to their response to the treatments. The cluster that contained a significant number of probes for ribosomal proteins (and elongation and initiation factors) is highlighted. (B) qRT-PCR confirmation of Rps8 levels in IPs from Cyp17iCre: RiboTag mice after acyline and LH administration. Data are the mean±SEM. Statistical analysis was performed using One-way Analysis of Variance (ANOVA) with Newman-Keuls multiple comparison post-hoc test. * p<0.05 vs acyline. (C) Western blot analysis of phospho-S6 ribosomal protein in MA-10 Leydig cells treated with LH (0.2 u/ml) for 1 h, with or without rapamycin (20 nM) pretreatment for 30 min. Cells were serum-starved overnight before treatments.
Top 50 Sertoli cell-specific transcripts. To determine the top Sertoli cell-specific transcripts, microarray analysis of IPs and their respective inputs from AMH-Cre: RiboTag mouse testis (n = 5) was performed and the ratio of the signal in the IP to the input was calculated and expressed as enrichment.
Gene ontology analysis of Sertoli cell-specific or highly enriched transcripts. Transcripts that showed an enrichment (IP/I) ratio of 5 fold or higher in IPs from AMH-Cre: RiboTag mice testes were analyzed. GO categories with an AdjP value <0.05 are shown.
Top 50 Leydig cell-specific transcripts. Leydig cell-specific transcripts were determined as described previously for Sertoli cells. Microarray analysis of Cyp17iCre: RiboTag mouse testis IPs and their respective inputs (n = 3) was performed and the enrichment was calculated as the ratio of the signal in the IPs compared to their inputs.
Kallikrein and Serpin family members enriched in Leydig cells. Table shows the members of the Kallikrein or Serpin family that have an enrichment (IP to input ratio) >4 in the Cyp17iCre: RiboTag pellets compared to their inputs by microarray analysis. Listed references confirm Leydig-cell specificity.
Gene ontology analysis of Leydig cell-specific or highly enriched transcripts. Transcripts that showed an enrichment (IP/I) ratio of 7 fold or higher in IPs from Cyp17iCre: RiboTag mouse testes were analyzed. GO categories with an AdjP value <0.01 are listed.
Sequences of primers used for qRT-PCR analysis.
Supplemental experimental procedures.
Sertoli cell enriched genes. Transcripts that show a fold change >2 when comparing the signal in the IP to their respective inputs (enrichment) by microarray analysis in saline-treated AMH-Cre: RiboTag mice (n = 5) are listed. Statistical analysis was performed using One-way Analysis of Variance (ANOVA, p<0.05).
Leydig cell enriched genes. Transcripts that show a fold change >2 when comparing the signal in the IP to their respective inputs (enrichment) by microarray analysis in Saline-treated Cyp17iCre: RiboTag mice (n = 3) are listed. Statistical analysis was performed using One-way Analysis of Variance (ANOVA, p<0.05).
We acknowledge John K. Amory for expert advice on the use of the GnRH antagonist acyline, Derek Pouchnik for performing the Affymetrix array work and Chris Small for helpful advice.
Conceived and designed the experiments: ES PSA MDG GSM. Performed the experiments: ES AQ PSA. Analyzed the data: ES RE EE JAM PSA GSM. Contributed reagents/materials/analysis tools: JAM CK. Wrote the paper: ES PSA MDG GSM.
- 1. Roth MY, Amory JK (2011) Pharmacologic development of male hormonal contraceptive agents. Clin Pharmacol Ther 89: 133–136.
- 2. Young EA (1995) The role of gonadal steroids in hypothalamic-pituitary-adrenal axis regulation. Crit Rev Neurobiol 9: 371–381.
- 3. Oakley AE, Clifton DK, Steiner RA (2009) Kisspeptin signaling in the brain. Endocr Rev 30: 713–743. doi: 10.1210/er.2009-0005
- 4. Plant TM (2008) Hypothalamic control of the pituitary-gonadal axis in higher primates: key advances over the last two decades. J Neuroendocrinol 20: 719–726. doi: 10.1111/j.1365-2826.2008.01708.x
- 5. Matzuk MM, Lamb DJ (2008) The biology of infertility: research advances and clinical challenges. Nat Med 14: 1197–1213. doi: 10.1038/nm.f.1895
- 6. Meachem SJ, Nieschlag E, Simoni M (2001) Inhibin B in male reproduction: pathophysiology and clinical relevance. Eur J Endocrinol 145: 561–571. doi: 10.1530/eje.0.1450561
- 7. Weinbauer GF, Nieschlag E (1995) Gonadotrophin control of testicular germ cell development. Adv Exp Med Biol 377: 55–65. doi: 10.1007/978-1-4899-0952-7_4
- 8. Nalam RL, Matzuk MM (2010) Local signalling environments and human male infertility: what we can learn from mouse models. Expert Rev Mol Med 12: e15. doi: 10.1017/s1462399410001468
- 9. Oatley JM, Brinster RL (2008) Regulation of spermatogonial stem cell self-renewal in mammals. Annu Rev Cell Dev Biol 24: 263–286. doi: 10.1146/annurev.cellbio.24.110707.175355
- 10. Aitken RJ, Baker MA, Doncel GF, Matzuk MM, Mauck CK, et al. (2008) As the world grows: contraception in the 21st century. J Clin Invest 118: 1330–1343. doi: 10.1172/jci33873
- 11. Eacker SM, Shima JE, Connolly CM, Sharma M, Holdcraft RW, et al. (2007) Transcriptional profiling of androgen receptor (AR) mutants suggests instructive and permissive roles of AR signaling in germ cell development. Mol Endocrinol 21: 895–907. doi: 10.1210/me.2006-0113
- 12. O'Shaughnessy PJ, Morris ID, Huhtaniemi I, Baker PJ, Abel MH (2009) Role of androgen and gonadotrophins in the development and function of the Sertoli cells and Leydig cells: data from mutant and genetically modified mice. Mol Cell Endocrinol 306: 2–8. doi: 10.1016/j.mce.2008.11.005
- 13. Willems A, De Gendt K, Allemeersch J, Smith LB, Welsh M, et al. (2010) Early effects of Sertoli cell-selective androgen receptor ablation on testicular gene expression. Int J Androl 33: 507–517. doi: 10.1111/j.1365-2605.2009.00964.x
- 14. McLean DJ, Friel PJ, Pouchnik D, Griswold MD (2002) Oligonucleotide microarray analysis of gene expression in follicle-stimulating hormone-treated rat Sertoli cells. Mol Endocrinol 16: 2780–2792. doi: 10.1210/me.2002-0059
- 15. Sadate-Ngatchou PI, Pouchnik DJ, Griswold MD (2004) Follicle-stimulating hormone induced changes in gene expression of murine testis. Mol Endocrinol 18: 2805–2816. doi: 10.1210/me.2003-0203
- 16. Sadate-Ngatchou PI, Pouchnik DJ, Griswold MD (2004) Identification of testosterone-regulated genes in testes of hypogonadal mice using oligonucleotide microarray. Mol Endocrinol 18: 422–433. doi: 10.1210/me.2003-0188
- 17. Small CL, Shima JE, Uzumcu M, Skinner MK, Griswold MD (2005) Profiling gene expression during the differentiation and development of the murine embryonic gonad. Biol Reprod 72: 492–501. doi: 10.1095/biolreprod.104.033696
- 18. Zhou Q, Shima JE, Nie R, Friel PJ, Griswold MD (2005) Androgen-regulated transcripts in the neonatal mouse testis as determined through microarray analysis. Biol Reprod 72: 1010–1019. doi: 10.1095/biolreprod.104.035915
- 19. Abel MH, Baban D, Lee S, Charlton HM, O'Shaughnessy PJ (2009) Effects of FSH on testicular mRNA transcript levels in the hypogonadal mouse. J Mol Endocrinol 42: 291–303. doi: 10.1677/jme-08-0107
- 20. Sanz E, Yang L, Su T, Morris DR, McKnight GS, et al. (2009) Cell-type-specific isolation of ribosome-associated mRNA from complex tissues. Proc Natl Acad Sci U S A 106: 13939–13944. doi: 10.1073/pnas.0907143106
- 21. Bridges PJ, Koo Y, Kang DW, Hudgins-Spivey S, Lan ZJ, et al. (2008) Generation of Cyp17iCre transgenic mice and their application to conditionally delete estrogen receptor alpha (Esr1) from the ovary and testis. Genesis 46: 499–505. doi: 10.1002/dvg.20428
- 22. Holdcraft RW, Braun RE (2004) Androgen receptor function is required in Sertoli cells for the terminal differentiation of haploid spermatids. Development 131: 459–467. doi: 10.1242/dev.00957
- 23. Miller JA, Cai C, Langfelder P, Geschwind DH, Kurian SM, et al. (2011) Strategies for aggregating gene expression data: the collapseRows R function. BMC Bioinformatics 12: 322. doi: 10.1186/1471-2105-12-322
- 24. Spandidos A, Wang X, Wang H, Seed B (2010) PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res 38: D792–799. doi: 10.1093/nar/gkp1005
- 25. Tai P, Ascoli M (2011) Reactive oxygen species (ROS) play a critical role in the cAMP-induced activation of Ras and the phosphorylation of ERK1/2 in Leydig cells. Mol Endocrinol 25: 885–893. doi: 10.1210/me.2010-0489
- 26. Musnier A, Leon K, Morales J, Reiter E, Boulo T, et al. (2012) mRNA-selective translation induced by FSH in primary Sertoli cells. Mol Endocrinol 26: 669–680. doi: 10.1210/me.2011-1267
- 27. Matsui H, Moriyama A, Takahashi T (2000) Cloning and characterization of mouse klk27, a novel tissue kallikrein expressed in testicular Leydig cells and exhibiting chymotrypsin-like specificity. Eur J Biochem 267: 6858–6865. doi: 10.1046/j.1432-1033.2000.01786.x
- 28. Matsui H, Takahashi T (2001) Mouse testicular Leydig cells express Klk21, a tissue kallikrein that cleaves fibronectin and IGF-binding protein-3. Endocrinology 142: 4918–4929. doi: 10.1210/en.142.11.4918
- 29. Matsui H, Takano N, Takahashi T (2005) Characterization of mouse glandular kallikrein 24 expressed in testicular Leydig cells. Int J Biochem Cell Biol 37: 2333–2343. doi: 10.1016/j.biocel.2005.05.011
- 30. Shima JE, McLean DJ, McCarrey JR, Griswold MD (2004) The murine testicular transcriptome: characterizing gene expression in the testis during the progression of spermatogenesis. Biol Reprod 71: 319–330. doi: 10.1095/biolreprod.103.026880
- 31. Martinez-Pomares L (2012) The mannose receptor. J Leukoc Biol 92: 1177–1186. doi: 10.1189/jlb.0512231
- 32. Otter M, Barrett-Bergshoeff MM, Rijken DC (1991) Binding of tissue-type plasminogen activator by the mannose receptor. J Biol Chem 266: 13931–13935.
- 33. Canipari R, Galdieri M (2000) Retinoid modulation of plasminogen activator production in rat Sertoli cells. Biol Reprod 63: 544–550. doi: 10.1095/biolreprod63.2.544
- 34. Hettle JA, Waller EK, Fritz IB (1986) Hormonal stimulation alters the type of plasminogen activator produced by Sertoli cells. Biol Reprod 34: 895–904. doi: 10.1095/biolreprod34.5.895
- 35. Narita M, Bu G, Herz J, Schwartz AL (1995) Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo. J Clin Invest 96: 1164–1168. doi: 10.1172/jci118105
- 36. Bartles JR, Wierda A, Zheng L (1996) Identification and characterization of espin, an actin-binding protein localized to the F-actin-rich junctional plaques of Sertoli cell ectoplasmic specializations. J Cell Sci 109 (Pt 6): 1229–1239.
- 37. Jameson SA, Natarajan A, Cool J, DeFalco T, Maatouk DM, et al. (2012) Temporal transcriptional profiling of somatic and germ cells reveals biased lineage priming of sexual fate in the fetal mouse gonad. PLoS Genet 8: e1002575. doi: 10.1371/journal.pgen.1002575
- 38. Ross AJ, Capel B (2005) Signaling at the crossroads of gonad development. Trends Endocrinol Metab 16: 19–25. doi: 10.1016/j.tem.2004.11.004
- 39. Swinnen JV, Tsikalas KE, Conti M (1991) Properties and hormonal regulation of two structurally related cAMP phosphodiesterases from the rat Sertoli cell. J Biol Chem 266: 18370–18377.
- 40. Vicini E, Conti M (1997) Characterization of an intronic promoter of a cyclic adenosine 3',5'-monophosphate (cAMP)-specific phosphodiesterase gene that confers hormone and cAMP inducibility. Mol Endocrinol 11: 839–850. doi: 10.1210/mend.11.7.9941
- 41. Kumar TR, Wang Y, Lu N, Matzuk MM (1997) Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet 15: 201–204. doi: 10.1038/ng0297-201
- 42. Ma X, Dong Y, Matzuk MM, Kumar TR (2004) Targeted disruption of luteinizing hormone beta-subunit leads to hypogonadism, defects in gonadal steroidogenesis, and infertility. Proc Natl Acad Sci U S A 101: 17294–17299. doi: 10.1073/pnas.0404743101
- 43. Hall SH, Berthelon MC, Avallet O, Saez JM (1991) Regulation of c-fos, c-jun, jun-B, and c-myc messenger ribonucleic acids by gonadotropin and growth factors in cultured pig Leydig cell. Endocrinology 129: 1243–1249. doi: 10.1210/endo-129-3-1243
- 44. Song KH, Park JI, Lee MO, Soh J, Lee K, et al. (2001) LH induces orphan nuclear receptor Nur77 gene expression in testicular Leydig cells. Endocrinology 142: 5116–5123. doi: 10.1210/endo.142.12.8525
- 45. Ujioka T, Russell DL, Okamura H, Richards JS, Espey LL (2000) Expression of regulator of G-protein signaling protein-2 gene in the rat ovary at the time of ovulation. Biol Reprod 63: 1513–1517. doi: 10.1095/biolreprod63.5.1513
- 46. Wu YL, Chuang HH, Kou YR, Lee TS, Lu SH, et al. (2008) Regulation of LH receptor and PGF2alpha receptor signaling by the regulator of G protein signaling 2 (RGS2) in human and mouse granulosa cells. Chin J Physiol 51: 282–291.
- 47. Clark BJ (2012) The mammalian START domain protein family in lipid transport in health and disease. J Endocrinol 212: 257–275. doi: 10.1530/joe-11-0313
- 48. Soccio RE, Adams RM, Maxwell KN, Breslow JL (2005) Differential gene regulation of StarD4 and StarD5 cholesterol transfer proteins. Activation of StarD4 by sterol regulatory element-binding protein-2 and StarD5 by endoplasmic reticulum stress. J Biol Chem 280: 19410–19418. doi: 10.1074/jbc.m501778200
- 49. Midzak AS, Chen H, Aon MA, Papadopoulos V, Zirkin BR (2011) ATP synthesis, mitochondrial function, and steroid biosynthesis in rodent primary and tumor Leydig cells. Biol Reprod 84: 976–985. doi: 10.1095/biolreprod.110.087460
- 50. Payne AH (1990) Hormonal regulation of cytochrome P450 enzymes, cholesterol side-chain cleavage and 17 alpha-hydroxylase/C17–20 lyase in Leydig cells. Biol Reprod 42: 399–404. doi: 10.1095/biolreprod42.3.399
- 51. Cancilla B, Davies A, Ford-Perriss M, Risbridger GP (2000) Discrete cell- and stage-specific localisation of fibroblast growth factors and receptor expression during testis development. J Endocrinol 164: 149–159. doi: 10.1677/joe.0.1640149
- 52. Colvin JS, Green RP, Schmahl J, Capel B, Ornitz DM (2001) Male-to-female sex reversal in mice lacking fibroblast growth factor 9. Cell 104: 875–889. doi: 10.1016/s0092-8674(01)00284-7
- 53. Cotton LM, O'Bryan MK, Hinton BT (2008) Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction. Endocr Rev 29: 193–216. doi: 10.1210/er.2007-0028
- 54. Lin YM, Tsai CC, Chung CL, Chen PR, Sun HS, et al. (2010) Fibroblast growth factor 9 stimulates steroidogenesis in postnatal Leydig cells. Int J Androl 33: 545–553. doi: 10.1111/j.1365-2605.2009.00966.x
- 55. Laslett AL, McFarlane JR, Hearn MT, Risbridger GP (1995) Requirement for heparan sulphate proteoglycans to mediate basic fibroblast growth factor (FGF-2)-induced stimulation of Leydig cell steroidogenesis. J Steroid Biochem Mol Biol 54: 245–250. doi: 10.1016/0960-0760(95)00138-p
- 56. Douglas NC, Heng K, Sauer MV, Papaioannou VE (2012) Dynamic expression of Tbx2 subfamily genes in development of the mouse reproductive system. Dev Dyn 241: 365–375. doi: 10.1002/dvdy.23710
- 57. Bakker ML, Boukens BJ, Mommersteeg MT, Brons JF, Wakker V, et al. (2008) Transcription factor Tbx3 is required for the specification of the atrioventricular conduction system. Circ Res 102: 1340–1349. doi: 10.1161/circresaha.107.169565
- 58. Davenport TG, Jerome-Majewska LA, Papaioannou VE (2003) Mammary gland, limb and yolk sac defects in mice lacking Tbx3, the gene mutated in human ulnar mammary syndrome. Development 130: 2263–2273. doi: 10.1242/dev.00431
- 59. Harrelson Z, Kelly RG, Goldin SN, Gibson-Brown JJ, Bollag RJ, et al. (2004) Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development. Development 131: 5041–5052. doi: 10.1242/dev.01378
- 60. Nelson RD, Stricklett P, Gustafson C, Stevens A, Ausiello D, et al. (1998) Expression of an AQP2 Cre recombinase transgene in kidney and male reproductive system of transgenic mice. Am J Physiol 275: C216–226.
- 61. Sharpe RM (1979) Gonadotrophin-induced accumulation of 'interstitial fluid' in the rat testis. J Reprod Fertil 55: 365–371. doi: 10.1530/jrf.0.0550365
- 62. Hedger MP, Muir JA (2000) Differential actions of gonadotropin-releasing hormone and human chorionic gonadotropin on interstitial fluid volume and immunoglobulin G concentrations in adult rat testis. J Androl 21: 747–752.
- 63. Wang X, Proud CG (2006) The mTOR pathway in the control of protein synthesis. Physiology (Bethesda) 21: 362–369. doi: 10.1152/physiol.00024.2006
- 64. Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, et al. (2012) A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485: 109–113. doi: 10.1038/nature11083
- 65. Tang H, Hornstein E, Stolovich M, Levy G, Livingstone M, et al. (2001) Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol Cell Biol 21: 8671–8683. doi: 10.1128/mcb.21.24.8671-8683.2001
- 66. Stolovich M, Tang H, Hornstein E, Levy G, Cohen R, et al. (2002) Transduction of growth or mitogenic signals into translational activation of TOP mRNAs is fully reliant on the phosphatidylinositol 3-kinase-mediated pathway but requires neither S6K1 nor rpS6 phosphorylation. Mol Cell Biol 22: 8101–8113. doi: 10.1128/mcb.22.23.8101-8113.2002
- 67. Jefferies HB, Reinhard C, Kozma SC, Thomas G (1994) Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. Proc Natl Acad Sci U S A 91: 4441–4445.
- 68. Hornstein E, Tang H, Meyuhas O (2001) Mitogenic and nutritional signals are transduced into translational efficiency of TOP mRNAs. Cold Spring Harb Symp Quant Biol 66: 477–484. doi: 10.1101/sqb.2001.66.477
- 69. Geyer PK, Meyuhas O, Perry RP, Johnson LF (1982) Regulation of ribosomal protein mRNA content and translation in growth-stimulated mouse fibroblasts. Mol Cell Biol 2: 685–693.
- 70. Levy S, Avni D, Hariharan N, Perry RP, Meyuhas O (1991) Oligopyrimidine tract at the 5' end of mammalian ribosomal protein mRNAs is required for their translational control. Proc Natl Acad Sci U S A 88: 3319–3323. doi: 10.1073/pnas.88.8.3319
- 71. Ingolia NT, Brar GA, Rouskin S, McGeachy AM, Weissman JS (2012) The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments. Nat Protoc 7: 1534–1550. doi: 10.1038/nprot.2012.086
- 72. Singh M, Ferrara N (2012) Modeling and predicting clinical efficacy for drugs targeting the tumor milieu. Nat Biotechnol 30: 648–657. doi: 10.1038/nbt.2286
- 73. Weiss RB, Atkins JF (2011) Molecular biology. Translation goes global. Science 334: 1509–1510. doi: 10.1126/science.1216974